Validity of a Self-administered Questionnaire Version of the Transition Dyspnea Index in Patients with COPD

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. 2016; Available from: http://www.goldcopd.com
   Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370(9589):741–750. DOI: 10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–2128. DOI: 10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med 2008; 102(9):1248–1256. DOI: 10.1016/j.rmed.2008.04.009
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc 2007; 4(2):145–168. DOI: 10.1513/pats.200611-159CC
   PubMedGoogle Scholar
• Laviolette L, Laveneziana P, ERS Research Seminar Faculty. Dyspnoea: A multidimensional and multidisciplinary approach. Eur Respir J 2014; 43(6):1750–1762. DOI: 10.1183/09031936.00092613
   PubMed Web of Science ®Google Scholar
• Figarska SM, Boezen HM, Vonk JM. Dyspnea severity, changes in dyspnea status and mortality in the general population: The Vlagtwedde/Vlaardingen study. Eur J Epidemiol 2012; 27(11):867–876. DOI: 10.1007/s10654-012-9736-0
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5):1434–1440.
   PubMed Web of Science ®Google Scholar
• Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31(2):416–469. DOI: 10.1183/09031936.00099306
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8):e13–64. DOI: 10.1164/rccm.201309-1634ST
   PubMed Web of Science ®Google Scholar
• Banzett RB, Schwartzstein RM. Dyspnea: Don't Just Look, Ask! Am J Respir Crit Care Med 2015; 192(12):1404–1406. DOI: 10.1164/rccm.201508-1637ED
   PubMed Web of Science ®Google Scholar
• Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax 2014; 69(4):393–394. DOI: 10.1136/thoraxjnl-2013-204701
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185(4):435–452. DOI: 10.1164/rccm.201111-2042ST
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM. Domains of dyspnea measurement. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, measurement, and management, 3rd ed. Boca Raton: CRC Press; 2014:85–98.
   Google Scholar
• Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2(5147):257–2066.
   PubMed Web of Science ®Google Scholar
• Brooks S. American Thoracic Society (ATS) task group on surveillance for respiratory hazards in the occupational setting. Surveillance for respiratory hazards. ATS News 1982; 8:12–16.
   Google Scholar
• Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85(6):751–758.
   Google Scholar
• Bausewein C, Farquhar M, Booth S, Gysels M, Higginson JJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007; 101(3):399–410. DOI: 10.1016/j.rmed.2006.07.003
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K. Longitudinal changes in dyspnea. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, measurement, and management, 3rd ed. Boca Raton: CRC Press; 2014:99–109.
   Google Scholar
• Mahler DA, Witek TJ. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005; 2(1):99–103.
   PubMedGoogle Scholar
• Witek TJ, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56(3):248–255.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009; 136(6):1473–1479. DOI: 10.1378/chest.09-0934
   PubMed Web of Science ®Google Scholar
• Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19(2):217–224.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(8):1084–1091. DOI: 10.1164/rccm.2112055
   PubMed Web of Science ®Google Scholar
• Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994; 105(4):1046–1052.
   PubMed Web of Science ®Google Scholar
• Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003; 167(6):880–888. DOI: 10.1164/rccm.200204-318OC
   PubMed Web of Science ®Google Scholar
• von Leupoldt A, Hahn E, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD. Lung 2008; 186(6):387–391. DOI: 10.1007/s00408-008-9089-3
   PubMed Web of Science ®Google Scholar
• von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011; 140(3):730–736. DOI: 10.1378/chest.10-2917
   PubMed Web of Science ®Google Scholar
• de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002; 121(4):1092–1098.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest 2007; 132(4):1283–1290. DOI: 10.1378/chest.07-0703
   PubMed Web of Science ®Google Scholar
• Mahler DA, Ward J, Fierro-Carrion G, WAterman LA, Lentine TF, Mejia-Alfaro R, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD 2004; 1(2):165–172.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi A, Coates R, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338. DOI: 10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5–40.
   PubMedGoogle Scholar
• Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145(2 Pt 1):467–470. DOI: 10.1164/ajrccm/145.2_Pt_1.467
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Mui‡ño A, et al. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med 2009; 103(9):1376–1382. DOI: 10.1016/j.rmed.2009.03.005
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest 1996; 109(5):1163–1168.
   Google Scholar
• Perez T, Burgel PR, Paillasseur J-L, Caillaud D, Deslée G, Chanez P, et al. Modified medical research council scale vs baseline dyspnea index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015; 10:1663–1672. DOI: 10.2147/COPD.S82408
   PubMed Web of Science ®Google Scholar
• Nieuwkerk PT, Sprangers MA. Each measure of patient-reported change provides useful information and is susceptible to bias: the need to combine methods to assess their relative validity. Arthritis Rheum 2009; 61(12):1623–1625. DOI: 10.1002/art.25030
   PubMed Web of Science ®Google Scholar
• Blome C, Augustin M. Measuring change in quality of life: bias in prospective and retrospective evaluation. Value Health J Int Soc Pharmacoeconomics Outcomes Res 2015; 18(1):110–115. DOI: 10.1016/j.jval.2014.10.007
   PubMed Web of Science ®Google Scholar